Everything You Need to Know from Neurologist Kenneth Wogensen, MD

Kensington Senior Living celebrates the recent FDA approval of Leqembi, a revolutionary new treatment for dementia. This breakthrough not only changes the landscape in the fight against Alzheimer's, but it also offers a beacon of hope for our residents, their families, and millions of other aging adults living with this disease.

Don't miss your chance to learn all about this groundbreaking new treatment. We are thrilled to partner with Neurologist Kenneth Wogensen, MD for a complimentary educational webinar. Whether you are an individual living with dementia, a family caregiver, a healthcare professional, or simply passionate about brain health, this event is for you!

What You Will Learn:

Basic Science: How Leqembi Fights Amyloid Plaques in the Brain

Efficacy: Clinical Trials Results and FDA Approval Process

Impact: Who is Eligible and Why, Plus Side Effects

Accessibility: Medicare Coverage